Minaris Advanced Therapies

Minaris is a global cell and gene therapy contract development and manufacturing organization (CDMO) and biosafety testing provider. It supports therapeutic innovators from investigational new drug (IND) development through commercial supply, offering process and analytical development, GMP manufacturing, quality and regulatory services, biosafety analytics, viral clearance, and product characterization for cell, gene, and biologic therapies across five sites on three continents.